Combined anti-HER2 and hormonal treatment in a patient with HR(+)HER2(+) clear-cell uterine carcinoma: A case report

Clear-cell carcinoma (CCC) of the uterus is an aggressive disease. Current international guidelines on the treatment of uterine carcinomas predominantly cover cancer with endometrioid histology, and clinicians tend to use the same approach for patients with non-endometrioid histology due to the abse...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordeeva, Olga O., Meshcheryakova, Lyudmila A., Karseladze, Apollon I., Meshcheryakova, Nadezhda A., Meshcheryakov, Andrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725212/
https://www.ncbi.nlm.nih.gov/pubmed/33363729
http://dx.doi.org/10.3892/mco.2020.2181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725212/
https://www.ncbi.nlm.nih.gov/pubmed/33363729
http://dx.doi.org/10.3892/mco.2020.2181

Ejemplares similares